OMEGA Study Group

EN / JP

🚀About

The OMEGA Study Group was founded in 2023 to research, develop, and disseminate technology that can help people with diabetes or pre-diabetes to lead better lives. We aim to achieve this by combining minimally or non-invasive blood glucose monitoring technology that uses a blood glucose surrogate biomarker called ‘glycated albumin’ with communication technology such as smartphone applications. We support the 'power to live a healthy life' that is inherent in everyone.

Constitution (Japanese)

230513_OMEGA Study Group会則_第1版.pdf

👥Members

Team Member

🩺Study

Latest clinical study

The digital intervention of a glycated albumin (GA) self-monitoring system for patients with type 2 diabetes: a randomized, open-label, non-intervention group controlled, single-center clinical study

Publication

Aihara M, Jinnouchi H, Yoshida A, Ijima H, Sakurai Y, Hayashi T, Koizumi C, Kubota T, Usami S, Yamauchi T, Sakata T, Kadowaki T, Kubota N. Evaluation of glycated albumin levels in tears and saliva as a marker in patients with diabetes mellitus. Diabetes Res Clin Pract. 2023;110637.
Aihara M, Irie T, Yasukawa K, Minoura I, Miyauchi N, Nishi M, Katayama N, Yachiku K, Jinnouchi H, Kadowaki T, Yamauchi T, Yatomi Y, Kubota N, Sekimizu K. Development of a high-performance liquid chromatographic glycated albumin assay using finger-prick blood samples. Clin Chim Acta. 2023;542:117272.
Aihara M, Kubota N, Yamauchi T. Development of Noninvasive Diabetes Management Method Using Glycated Albumin in Tears Diabetes 2020;69(Supplement_1):887-P
Aihara M, Hayashi T, Koizumi C, Sakurai Y, Sawada M, Kubota T, Kadowaki T, Yamauchi T, Kubota N. Bi-weekly Glycated Albumin Measurement was Useful to Encourage Behavioral Changes in People with Type 2 Diabetes Mellitus. Diabetes Ther 14, 1711–1721 (2023).